Results 161 to 170 of about 116,664 (270)

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. [PDF]

open access: yesObesity (Silver Spring)
Bays HE   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy